Comparison of National Lung Cancer Resection Outcomes to Screening Trial Outcomes
Since the National Cancer Database (NCDB) captures over 70% of all cancer diagnoses, we aim to compare perioperative outcomes (e.g. 30-day and 90-day mortality) using the National Cancer Database (NCDB) and the NLST datasets to compare "current real world" outcomes to those observed in screening trials. We plan to evaluate risk-adjusted perioperative outcomes by facility for patients undergoing lung cancer resection in each cohort. We will then compare facility-level perioperative outcomes to determine if significant variations in outcomes are observed for surgical resection under performed under screening trials versus a broader national cohort.
Data from this study will inform future studies aimed at understanding factors underlying variations in outcomes for patients undergoing lung cancer resection under screening programs.
1. Compare patient and disease factors between NLST dataset and a national dataset (NCDB) of patients undergoing lung cancer treatment
2. Identify variation in facility-level perioperative (e.g.30-day and 90-day mortality) risk-adjusted outcomes following lung cancer resection between NLST dataset and a national dataset (NCDB) reflective of national practice patterns/outcomes
Nathaniel R. Evans, MD, Sidney Kimmel Medical College, Thomas Jefferson University
Richard Zheng, MD, Sidney Kimmel Medical College, Thomas Jefferson University
Samantha Savitch, Sidney Kimmel Medical College, Thomas Jefferson University